199 related articles for article (PubMed ID: 35647650)
21. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
[TBL] [Abstract][Full Text] [Related]
22. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.
Liu M; Zeng R; Zhang L; Li D; Lv G; Shen Y; Zheng H; Zhang Q; Zhao J; Zheng N; Liu W
Antimicrob Agents Chemother; 2015 Jul; 59(7):4321-5. PubMed ID: 25896700
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Monzon A; Cuenca-Estrella M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2468-72. PubMed ID: 18474574
[TBL] [Abstract][Full Text] [Related]
24. The cytochrome P450 reductase CprA is a rate-limiting factor for Cyp51A-mediated azole resistance in
Kühbacher A; Merschak P; Haas H; Liebl M; Müller C; Gsaller F
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0091823. PubMed ID: 37815358
[TBL] [Abstract][Full Text] [Related]
25.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
26. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
Riat A; Plojoux J; Gindro K; Schrenzel J; Sanglard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437612
[No Abstract] [Full Text] [Related]
27. In Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus.
Warrilow AG; Parker JE; Price CL; Nes WD; Kelly SL; Kelly DE
Antimicrob Agents Chemother; 2015 Dec; 59(12):7771-8. PubMed ID: 26459890
[TBL] [Abstract][Full Text] [Related]
28. A Novel Combination of
Macedo D; Brito Devoto T; Pola S; Finquelievich JL; Cuestas ML; Garcia-Effron G
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423948
[TBL] [Abstract][Full Text] [Related]
29. cyp51A-based mechanism of azole resistance in Aspergillus fumigatus: Illustration by a new 3D Structural Model of Aspergillus fumigatus CYP51A protein.
Liu M; Zheng N; Li D; Zheng H; Zhang L; Ge H; Liu W
Med Mycol; 2016 May; 54(4):400-8. PubMed ID: 26768370
[TBL] [Abstract][Full Text] [Related]
30. Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
Castanheira M; Collingsworth TD; Davis AP; Deshpande LM; Pfaller MA
Mycoses; 2021 Oct; 64(10):1279-1290. PubMed ID: 33705591
[TBL] [Abstract][Full Text] [Related]
31. Azole Resistance-Associated Regulatory Motifs within the Promoter of
Kühbacher A; Peiffer M; Hortschansky P; Merschak P; Bromley MJ; Haas H; Brakhage AA; Gsaller F
Microbiol Spectr; 2022 Jun; 10(3):e0120922. PubMed ID: 35575535
[TBL] [Abstract][Full Text] [Related]
32. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
[TBL] [Abstract][Full Text] [Related]
33. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
34. New Insights into the Cyp51 Contribution to Azole Resistance in
Pérez-Cantero A; López-Fernández L; Guarro J; Capilla J
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061160
[TBL] [Abstract][Full Text] [Related]
35. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
[TBL] [Abstract][Full Text] [Related]
36. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Mutations Contributing to Azole Tolerance of Aspergillus fumigatus through
Toyotome T; Onishi K; Sato M; Kusuya Y; Hagiwara D; Watanabe A; Takahashi H
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0265720. PubMed ID: 34125587
[TBL] [Abstract][Full Text] [Related]
38. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
39. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.
Garcia-Effron G; Mellado E; Gomez-Lopez A; Alcazar-Fuoli L; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 May; 49(5):2119-21. PubMed ID: 15855543
[TBL] [Abstract][Full Text] [Related]
40. Coordinated Regulation of Membrane Homeostasis and Drug Accumulation by Novel Kinase STK-17 in Response to Antifungal Azole Treatment.
Hu C; Zhou M; Cao X; Xue W; Zhang Z; Li S; Sun X
Microbiol Spectr; 2022 Feb; 10(1):e0012722. PubMed ID: 35196787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
